Published in J Pharmacol Exp Ther on December 01, 1986
Comparison of the inhibition of insulin release by activation of adenosine and alpha 2-adrenergic receptors in rat beta-cells. Biochem J (1989) 0.81
Adenosine inhibitory effect on enhanced growth of aortic smooth muscle cells from streptozotocin-induced diabetic rats. Br J Pharmacol (1996) 0.79
A₁ adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice. Cardiovasc Res (2014) 0.77
A mesoscale phytoplankton bloom in the polar Southern Ocean stimulated by iron fertilization. Nature (2000) 4.36
Ruptured aneurysms of the sinus of Valsalva in Oriental patients. J Thorac Cardiovasc Surg (1990) 4.28
Insulin resistance and cigarette smoking. Lancet (1992) 4.10
Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes (1988) 3.67
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A (2000) 3.48
Switching doctors: predictors of voluntary disenrollment from a primary physician's practice. J Fam Pract (2001) 3.41
Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab (2001) 3.31
Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA (1991) 3.01
Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia (2007) 2.71
Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest (1970) 2.68
Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med (1989) 2.63
Coronary artery disease in Chinese males without hypercholesterolaemia. J Intern Med (1990) 2.54
A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism (2000) 2.49
Fructose-induced insulin resistance and hypertension in rats. Hypertension (1987) 2.43
Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women. Diabetes Care (1997) 2.40
The quality of physician-patient relationships. Patients' experiences 1996-1999. J Fam Pract (2001) 2.32
Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care (2000) 2.22
Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab (1998) 2.21
Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med (1976) 2.13
Doctor discontent. A comparison of physician satisfaction in different delivery system settings, 1986 and 1997. J Gen Intern Med (2001) 2.12
Implementing clinical practice guidelines while taking account of changing evidence: ATHENA DSS, an easily modifiable decision-support system for managing hypertension in primary care. Proc AMIA Symp (2000) 2.12
Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex. Science (1992) 2.02
Role of insulin in endogenous hypertriglyceridemia. J Clin Invest (1967) 2.00
Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1987) 1.96
Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J Clin Invest (1974) 1.92
Trauma outcome improves following the advanced trauma life support program in a developing country. J Trauma (1993) 1.91
Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care (1990) 1.90
Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol (1985) 1.89
Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia (1994) 1.87
Breast-cancer diagnosis with nipple fluid bFGF. Lancet (2000) 1.86
A combinatorial approach to materials discovery. Science (1995) 1.84
Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med (1974) 1.84
Kinetics of triglyceride turnover of very low density lipoproteins of human plasma. J Clin Invest (1965) 1.83
Insulin resistance in pulmonary arterial hypertension. Eur Respir J (2008) 1.80
Isolation and Properties of Nuclei from Control and Auxin-treated Soybean Hypocotyl. Plant Physiol (1975) 1.80
Activation of CLN1 and CLN2 G1 cyclin gene expression by BCK2. Mol Cell Biol (1995) 1.78
Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest (1975) 1.69
Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women. Am J Clin Nutr (1997) 1.62
Bovine galactosyltransferase: identification of a clone by direct immunological screening of a cDNA expression library. Proc Natl Acad Sci U S A (1986) 1.59
Asymmetric discounting in intertemporal choice: a query-theory account. Psychol Sci (2007) 1.58
Venodilation in Raynaud's disease. Lancet (1993) 1.54
Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism (1998) 1.54
Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol (2001) 1.53
Insulin binding to isolated human adipocytes. Diabetes (1974) 1.53
Effects of age and obesity on insulin binding to isolated adipocytes. Endocrinology (1975) 1.50
Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells. Cell Tissue Res (2001) 1.50
Insulin binding in diabetes. Relationships with plasma insulin levels and insulin sensitivity. Diabetes (1977) 1.49
Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest (1992) 1.49
Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin. Diabetes Care (1998) 1.49
Postural and action myoclonus in patients with parkinsonian type multiple system atrophy. Mov Disord (2000) 1.49
Effect of age on glucose tolerance and glucose uptake in healthy individuals. J Am Geriatr Soc (1989) 1.47
From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM. Diabetologia (1997) 1.46
Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab (1988) 1.46
Comparison of the Hanbury Brown-Twiss effect for bosons and fermions. Nature (2007) 1.46
Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care (1994) 1.44
Much ado about (almost) nothing. Diabetes Care (1997) 1.43
Enhanced glucose utilization during prolonged glucose clamp studies. Diabetes (1981) 1.42
Synthesis and anticonvulsant activity of enaminones. J Med Chem (1992) 1.42
Alpha-adrenergic receptor subtypes: quantitative assessment by ligand binding. Life Sci (1979) 1.42
Insulin resistance and cigarette smoking. Lancet (1992) 1.42
Blood hepatocyte growth factor levels in chronic renal failure patients. Nephron (1994) 1.41
Asynchronous synthesis of erythrocyte membrane proteins. Proc Natl Acad Sci U S A (1976) 1.41
Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab (1987) 1.40
Increased urinary transforming growth factor-beta(1) excretion in children with posterior urethral valves. Urology (2000) 1.40
Relation between dietary vitamin intake and resistance to insulin-mediated glucose disposal in healthy volunteers. Am J Clin Nutr (1996) 1.40
Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med (1992) 1.39
Coronary heart disease in the absence of hypercholesterolaemia. J Intern Med (1990) 1.39
Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue. Obesity (Silver Spring) (2009) 1.39
Insulin delivery rate into plasma in normal and diabetic subjects. J Clin Invest (1968) 1.38
Decreased insulin binding to lymphocytes from diabetic subjects. J Clin Invest (1974) 1.37
Synthesis and anticonvulsant activity of enaminones. 2. Further structure-activity correlations. J Med Chem (1993) 1.36
T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4. J Biol Chem (2000) 1.36
A quantitative ultrastructural study of microtubule content and secretory granule accumulation in parathyroid glands of phosphate- and colchicine-treated rats. J Clin Invest (1975) 1.35
Quantitative analysis of transforming growth factor-beta 1 in ligamentum flavum of lumbar spinal stenosis and disc herniation. Spine (Phila Pa 1976) (2001) 1.35
Relationship between in vivo insulin resistance and decreased insulin receptors in obese man. J Clin Endocrinol Metab (1979) 1.34
Banting Lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition (1997) 1.34
Insulin-independent diabetes mellitus: metabolic characteristics. Metabolism (1980) 1.32
Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man. J Clin Invest (1966) 1.32
Part-time physicians. Physician workload and patient-based assessments of primary care performance. Arch Fam Med (2000) 1.30
Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab (1985) 1.30
Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol Exp Ther (1986) 1.28
Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes (1984) 1.27
Insulin and blood pressure in obesity. Hypertension (1985) 1.27
Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest (2005) 1.27
The human lymphocyte: a model for the study of insulin-receptor interaction. J Clin Endocrinol Metab (1974) 1.25
Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1987) 1.24
Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens (1989) 1.24
Distribution and content of microtubules in relation to the transport of lipid. An ultrastructural quantitative study of the absorptive cell of the small intestine. J Cell Biol (1977) 1.23
Alpha-adrenergic receptor subtypes. N Engl J Med (1980) 1.23
Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane. Blood (1999) 1.23
Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure. Eur J Clin Invest (2006) 1.22
The molecular basis of selective permeability of connexins is complex and includes both size and charge. Braz J Med Biol Res (2000) 1.22
Agonist versus antagonist binding to alpha-adrenergic receptors. Proc Natl Acad Sci U S A (1980) 1.22
Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab (2000) 1.21
Prevalence of plasma lipoprotein abnormalities in a free-living population of the Central Valley, California. Circulation (1972) 1.21
A role for insulin in the aetiology and course of hypertension? Lancet (1987) 1.21